The Pierre Fabre Foundation was recognized as a public utility in 1999 and its mission is to help third-world countries to obtain quality drugs, ensure better quality control of drugs, use local therapeutic resources and train scientists for the inspection of drugs. Mr Pierre Fabre stated that “In order to do this, we design and develop innovative solutions that contribute to peoples well-being, from health to beauty. We achieve this by cooperating with health-care professionals, our trusted partners worldwide, by drawing relentless inspiration from nature and plants, and by placing pharmaceutical ethics at the very heart of our operations”. The Pierre Fabre group has a unique shareholding structure that guarantees its continuity and independence, while perpetuating the humanist values of its founder. The majority shareholder is the Pierre Fabre Foundation, which is a government-recognized public-interest organization. It has also developed its employee stock ownership plan, and employees thus form the second-largest group of shareholders. This structure is unique in France and is aimed at ensuring the long-term stability of the companys capital.
The following is the list of scholars from Pierre Fabre who contributed and/or serves as editors for one or more OMICS International journals and conferences
The following is the list of articles by scholars from Pierre Fabre that are published in OMICS International journals.
Efficacy and Safety of a Topical Pediatric Gel in Infants with Pityriasis capitis: A Randomized Phase III Controlled Trial
The following is the list of proceedings by scholars from Pierre Fabre that are published in OMICS International journals and conferences.